Test2LearnTM Community-based Pharmacogenomics Certificate Program


Philip Empey, PharmD, PhD, BCPS
is an Assistant Professor in the Department of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy and Associate Director for Pharmacogenomics of the Pitt/UPMC Institute of Personalized Medicine.  After receiving his PharmD from the University of Rhode Island, Dr. Empey completed PGY1 and PGY2 residencies in Pharmacy Practice and Critical Care at the University of Kentucky Healthcare, earned a PhD in Clinical Pharmaceutical Sciences at the University of Kentucky, and completed postdoctoral training at the University of Pittsburgh.  Dr. Empey conducts NIH-funded clinical and translational research aimed at understanding the mechanisms of the variability in drug response in critically-ill patients.  He also leads the PreCISE-Rx and Test2Learn teams to implement pharmacogenomics clinical, research, and educational initiatives.  Current research interests include understanding the impact of xenobiotic transporters following neurological injury, pharmacogenomics clinical implementation, transporter pharmacogenomics, and of collection of medication-related phenotype data to drive genotype-phenotype discovery.

 

James M. Stevenson, PharmD, MS is an assistant professor of pharmacy and therapeutics at the University of Pittsburgh School of Pharmacy. He received his PharmD from the University of Michigan and completed a pharmacy practice residency, pharmacogenomics/psychopharmacology fellowship, and Masters degree in Clinical & Translational Science at the University of Illinois at Chicago. He conducts translational research focusing on identifying genetic predictors of drug tolerability and efficacy, primarily in the area of psychiatric medications. In addition to his research, he played an integral role in the clinical deployment of clinical pharmacogenomics in both Chicago and Pittsburgh, and currently consults on patients treated by the Clinical Pharmacogenomics Consult Service at UPMC Presbyterian Hospital.

 

James C. Coons, PharmD, BCPS (AQ-CV) is an associate professor in the Department of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy and a clinical pharmacist specializing in cardiology at UPMC Presbyterian Shadyside. He is also the PGY-2 cardiology pharmacy residency program director at UPMC Presbyterian Shadyside. After receiving his PharmD from the University of Pittsburgh in 2000, he completed a PGY-1 residency in pharmacy practice at the University of Virginia Health System in Charlottesville in 2002. From there, he returned to Pittsburgh to complete a PGY-2 specialty residency in cardiology pharmacy practice at the University of Pittsburgh in 2003. From 2003 to 2012, Coons was a clinical pharmacy specialist in cardiology at Allegheny General Hospital (AGH) in Pittsburgh. Coons' clinical practice sites at UPMC include the cardiac intensive care unit and the pulmonary hypertension clinic. His research interests include genetic contributions to bleeding and secondary cardiac events after percutaneous coronary intervention and management of advanced heart failure and pulmonary vascular diseases.

 

Lucas Berenbrok, PharmD is an Assistant Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy, joining faculty in 2014. He is the Program Director of PittPharmacy's community service practice, SilverScripts, and mentors students on community-based research and service. His practice interests include expanding community-based care through immunizations, comprehensive medication management, and employee wellness.  He focuses his research on community pharmacist provided services and its impact on ensuring quality patient care. Dr. Berenbrok is a graduate of the University of Pittsburgh School of Pharmacy, and a graduate of the PGY1 Community Pharmacy Practice Residency with Kerr Drug/Walgreens and the UNC Eshelman School of Pharmacy in Chapel Hill, NC.

 

Solomon M. Adams, PharmD is a Fellow and PhD candidate at the University of Pittsburgh school of pharmacy. He joined Pitt pharmacy after receiving his PharmD from Shenandoah University in 2013. As a PhD student, his research is focused on how genetic variations impact the brain’s ability to recovery after traumatic injury. In addition to research, he works as part of the research team for the clinical deployment of pharmacogenomics at UPMC Presbyterian Hospital and as a bioinformatician supporting pharmacogenomic data interpretation and analysis.

 

 


© 2018 National Association of Chain Drug Stores, Inc.  All rights reserved.